Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form
|
Product containing precisely bacitracin 250 unit/1 gram and neomycin sulfate 5 milligram/1 gram and sulfacetamide sodium 60 milligram/1 gram conventional release cutaneous powder (clinical drug)
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder
Id1230118007
StatusDefined
Has manufactured dose formCutaneous powder
Has BoSSSulfacetamide sodium
Has concentration strength denominator unitg
Has concentration strength numerator unitmg
Has precise active ingredientSulfacetamide sodium
Has BoSSbacitracine
Has concentration strength denominator unitg
Has concentration strength numerator unitUnit
Has precise active ingredientbacitracine
Has BoSSneomycinesulfaat
Has concentration strength denominator unitg
Has concentration strength numerator unitmg
Has precise active ingredientneomycinesulfaat